Lizzo shares more of the “deeply suicidal” period in her life that led to her weight loss and mental health journey.

Researchers say a woman struggling with obesity who couldn't resist eating fatty foods experienced declines in her cravings ...

Lizzo opened up in a new personal essay about her mental health struggles before going on her weight loss journey and the ...

Key Takeaways A new AGA poll, funded by drug maker Novo Nordisk, shows that a large majority of Americans view obesity as a ...

Novo Nordisk said on Tuesday its experimental obesity drug, amycretin, showed statistically significant weight loss of up to 14.5% at 36 weeks in patients with type 2 diabetes in a mid-stage study.

An oral version of the GLP-1 drug semaglutide failed to significantly slow the disease's progression compared to a placebo.

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, ...

An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow the progression ...

Real-world analysis reveals that glucagon-like peptide-1 receptor agonists provide cardiovascular benefits for adults with type 2 diabetes. Glucagon-like peptide-1 receptor agonists reduce major ...

Larger studies are needed to provide more meaningful results. The present evidence supports the use of cyproterone acetate or spironolactone ideally combined with ethinylestradiol as the best ...

A major new study has found that a drug called semaglutide can greatly improve heart health in people who are overweight or ...

Family files wrongful death lawsuit against Sigma Chi fraternity at UT, alleging brutal hazing practices drove freshman ...